<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Serre K</submitter><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>e20731</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3108993</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Although in vitro IL-4 directs CD4 T cells to produce T helper 2 (Th2)-cytokines, these cytokines can be induced in vivo in the absence of IL-4-signalling. Thus, mechanism(s), different from the in vitro pathway for Th2-induction, contribute to in vivo Th2-differentiation. The pathway for in vivo IL-4-independent Th2-differentiation has yet to be characterized.&lt;h4>Findings&lt;/h4>Helios (ikzf2), a member of the Ikaros transcription regulator family, is expressed in thymocytes and some antigen-matured T cells as well as in regulatory T cells. It has been proposed that Helios is a specific marker for thymus-derived regulatory T cells. Here, we show that mouse ovalbumin-specific CD4 (OTII) cells responding to alum-precipitated ovalbumin (alumOVA) upregulate Th2 features - GATA</pubmed_abstract><journal>PloS one</journal><pubmed_title>Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.</pubmed_title><pmcid>PMC3108993</pmcid><funding_grant_id>G8402371</funding_grant_id><funding_grant_id>G9818340</funding_grant_id><funding_grant_id>G9818340B</funding_grant_id><funding_grant_id>G0701275</funding_grant_id><funding_grant_id>BB/F022778/1</funding_grant_id><pubmed_authors>Desanti G</pubmed_authors><pubmed_authors>Bobat S</pubmed_authors><pubmed_authors>Mohr E</pubmed_authors><pubmed_authors>Serre K</pubmed_authors><pubmed_authors>Cunningham AF</pubmed_authors><pubmed_authors>Bird R</pubmed_authors><pubmed_authors>Toellner KM</pubmed_authors><pubmed_authors>Maclennan IC</pubmed_authors><pubmed_authors>Chan S</pubmed_authors><pubmed_authors>Kastner P</pubmed_authors><pubmed_authors>Benezech C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.</name><description>&lt;h4>Background&lt;/h4>Although in vitro IL-4 directs CD4 T cells to produce T helper 2 (Th2)-cytokines, these cytokines can be induced in vivo in the absence of IL-4-signalling. Thus, mechanism(s), different from the in vitro pathway for Th2-induction, contribute to in vivo Th2-differentiation. The pathway for in vivo IL-4-independent Th2-differentiation has yet to be characterized.&lt;h4>Findings&lt;/h4>Helios (ikzf2), a member of the Ikaros transcription regulator family, is expressed in thymocytes and some antigen-matured T cells as well as in regulatory T cells. It has been proposed that Helios is a specific marker for thymus-derived regulatory T cells. Here, we show that mouse ovalbumin-specific CD4 (OTII) cells responding to alum-precipitated ovalbumin (alumOVA) upregulate Th2 features - GATA</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011</publication><modification>2026-04-14T13:36:50.811Z</modification><creation>2025-05-18T11:23:32.848Z</creation></dates><accession>S-EPMC3108993</accession><cross_references><pubmed>21677778</pubmed><doi>10.1371/journal.pone.0020731</doi></cross_references></HashMap>